Singhe Hospitals PLC (COSE:SINH.N0000)
Sri Lanka · Delayed Price · Currency is LKR 0.00
0.00 (0.00%)
Price not available due to exchange restrictions
Singhe Hospitals Income Statement
Financials in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 2,147 | 1,926 | 1,507 | 1,272 | 1,072 | 1,002 | |
Revenue Growth | 24.09% | 27.82% | 18.42% | 18.72% | 6.99% | 43.03% |
Cost of Revenue | 687.63 | 654.36 | 521.15 | 507.42 | 461.08 | 452.89 |
Gross Profit | 1,459 | 1,272 | 985.52 | 764.89 | 610.62 | 548.81 |
Selling, General & Admin | 1,066 | 948.53 | 802.8 | 676.82 | 531.61 | 499.46 |
Other Operating Expenses | 42.71 | -2.02 | -1.12 | -0.33 | -0.67 | -0.67 |
Operating Expenses | 1,109 | 946.51 | 801.68 | 676.49 | 530.94 | 498.79 |
Operating Income | 350.21 | 325.03 | 183.84 | 88.4 | 79.68 | 50.02 |
Interest Expense | -26.64 | -27.52 | -30.38 | -55.14 | -61.57 | -33.9 |
Interest & Investment Income | 15.76 | 15.76 | 2.7 | 1.5 | 1.11 | 0.01 |
Other Non Operating Income (Expenses) | -13.65 | -13.65 | -9.19 | -2.27 | -3.28 | -1.98 |
EBT Excluding Unusual Items | 325.67 | 299.62 | 146.97 | 32.49 | 15.94 | 14.14 |
Gain (Loss) on Sale of Investments | 0.01 | 0.01 | -0 | -0 | 0.01 | 0 |
Gain (Loss) on Sale of Assets | 1.54 | 1.54 | - | - | - | - |
Pretax Income | 327.22 | 301.17 | 146.97 | 32.49 | 15.95 | 14.14 |
Income Tax Expense | 85.44 | 85.16 | 30.79 | 7.86 | 28.67 | -2.27 |
Net Income | 241.78 | 216.01 | 116.18 | 24.63 | -12.73 | 16.41 |
Net Income to Common | 241.78 | 216.01 | 116.18 | 24.63 | -12.73 | 16.41 |
Net Income Growth | 28.40% | 85.92% | 371.73% | - | - | 613.87% |
Shares Outstanding (Basic) | 430 | 431 | 431 | 431 | 431 | 431 |
Shares Outstanding (Diluted) | 430 | 431 | 431 | 431 | 431 | 431 |
Shares Change | -3.38% | - | - | - | - | - |
EPS (Basic) | 0.56 | 0.50 | 0.27 | 0.06 | -0.03 | 0.04 |
EPS (Diluted) | 0.56 | 0.50 | 0.27 | 0.06 | -0.03 | 0.04 |
EPS Growth | 32.89% | 85.93% | 371.74% | - | - | 613.96% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 105.55 | 131.92 | 161.44 | 75.16 | 75.13 | 39.32 |
Free Cash Flow Per Share | 0.24 | 0.31 | 0.37 | 0.17 | 0.17 | 0.09 |
Gross Margin | 67.97% | 66.02% | 65.41% | 60.12% | 56.98% | 54.79% |
Operating Margin | 16.31% | 16.88% | 12.20% | 6.95% | 7.43% | 4.99% |
Profit Margin | 11.26% | 11.22% | 7.71% | 1.94% | -1.19% | 1.64% |
Free Cash Flow Margin | 4.92% | 6.85% | 10.71% | 5.91% | 7.01% | 3.92% |
EBITDA | 428.25 | 387.29 | 240.79 | 135.99 | 134.69 | 127.17 |
EBITDA Margin | 19.95% | 20.11% | 15.98% | 10.69% | 12.57% | 12.70% |
D&A For EBITDA | 78.04 | 62.26 | 56.94 | 47.6 | 55.01 | 77.16 |
EBIT | 350.21 | 325.03 | 183.84 | 88.4 | 79.68 | 50.02 |
EBIT Margin | 16.31% | 16.88% | 12.20% | 6.95% | 7.43% | 4.99% |
Effective Tax Rate | 26.11% | 28.28% | 20.95% | 24.19% | 179.80% | - |